Connection

Search Results to Rangaraj Selvarangan

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Selvarangan, Rangaraj

One or more keywords matched the following properties of Selvarangan, Rangaraj

Property	Value
keywords	Epidemiology of Infectious Diseases
keywords	Improved Laboratory Detection of Infectious Diseases
keywords	Vaccine Therapies
research overview	Dr. Selvarangan is the Director of the Clinical Microbiology and Molecular Infectious Diseases Laboratory in Children’s Mercy Hospital accredited by College of American Pathologists. He has more than fifteen years of experience with directorship of high complexity clinical laboratory testing and research in the area of laboratory test evaluation and selection for implementation in routine clinical care. His research area encompasses advanced diagnostics for infectious diseases, epidemiology of infections in children, vaccine related studies, biomarker discovery and host response to infections and interventions to improve patient care and outcomes. His clinical research experience also includes federal funding and more than 100 clinical trials supported by In vitro diagnostic industry. His research team specializes in large volume prospective enrollment of children in clinical trials for infectious diseases in outpatient and inpatient settings. As the founding Principal Investigator of Kansas City-New Vaccine Surveillance Network (KC-NVSN) program since 2009, sponsored by Centers for Disease Control and Prevention, he has direct working knowledge on establishment and collaboration of multisite national networks.

One or more keywords matched the following items that are connected to Selvarangan, Rangaraj

Item Type	Name
Concept	Communicable Diseases
Concept	Drug Therapy, Combination
Concept	Treatment Outcome
Concept	Infectious Disease Transmission, Vertical
Concept	Communicable Diseases, Emerging
Academic Article	Severe enterovirus 68 respiratory illness in children requiring intensive care management.
Academic Article	Outcome of children with rhinovirus detection prior to allogeneic hematopoietic cell transplant.
Academic Article	Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients.
Academic Article	Treatment outcomes for nontuberculous mycobacterial cervicofacial lymphadenitis in children based on the type of surgical intervention.
Academic Article	Experimental transmission of Neisseria gonorrhoeae from pregnant rat to fetus.
Academic Article	Demographics and microbiology of otorrhea through patent tubes failing ototopical and/or oral antibiotic therapy.
Academic Article	Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays.
Academic Article	Microbiology and antimicrobial treatment of pediatric cervical lymphadenitis requiring surgical intervention.
Academic Article	Automated Real-Time Collection of Pathogen-Specific Diagnostic Data: Syndromic Infectious Disease Epidemiology.
Academic Article	Emergence of Parechovirus A4 Central Nervous System Infections among Infants in Kansas City, Missouri, USA.
Academic Article	Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.
Academic Article	Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.
Grant	Kansas City - New Vaccine Surveillance Network (KC-NVSN)
Academic Article	Influenza clinical testing and oseltamivir treatment in hospitalized children with acute respiratory illness, 2015-2016.
Academic Article	Treatment of COVID-19 symptoms with over the counter (OTC) medicines used for treatment of common cold and flu.

Search Criteria

Infectious disease
therapeutic
development